Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Life Sciences

Donaldson (NYSE:DCI) reported record third-quarter fiscal 2026 sales, adjusted operating margin and adjusted earnings per share, as strength in its Mobile Solutions and Life Sciences segments helped offset operational pressure in Industrial Solutions. President and CEO Rich Lewis said the quarter m

MarketBeat

Diploma H1 Earnings Call Highlights

Diploma (LON:DPLM) reported what management described as a “very strong” first half for the six months ended March 31, 2026, with double-digit organic growth, higher margins and upgraded full-year expectations. Chief Executive Officer Johnny Thomson said the company delivered “a very strong perform

MarketBeat

INNOVATE Q1 Earnings Call Highlights

INNOVATE (NYSE:VATE) reported higher first-quarter revenue and a narrower loss as growth in its infrastructure business offset weaker results in its Life Sciences and Spectrum segments, management said on the company’s first-quarter 2026 earnings call. Interim CEO Paul Voigt said the company delive

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

STERIS Q4 Earnings Call Highlights

STERIS (NYSE:STE) reported a stronger fiscal 2026 overall despite a lighter fourth quarter, with executives pointing to record annual revenue, resilient procedure demand and continued pricing gains, while also outlining expectations for mid- to high-single-digit growth in fiscal 2027. Senior Vice P

MarketBeat

Donaldson Starts The Year Strong, Raises Annual Outlook

Donaldson Company, Inc. (NYSE:DCI) stock rose Thursday after the company reported first-quarter fiscal 2026 results.

Benzinga

Are Wall Street Analysts Bullish on STERIS Stock?

Despite STERIS' outperformance relative to the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

Barchart

180 Life Sciences Extends Rally After Revealing $349 Million Ethereum Reserve

Shares of 180 Life Sciences Corp. (NASDAQ:ATNF) climbed Wednesday, extending the previous day's rally, after the company revealed it had accumulated more than $349 million in Ethereum (CRYPTO: ETH) as part of its revamped treasury strategy.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

180 Life Sciences (ATNF) Stock Is Surging Tuesday As Ethereum Crosses $4,400: What's Going On?

180 Life Sciences Corp (NASDAQ:ATNF) shares are soaring Tuesday after the company provided an update on its Ethereum (CRYPTO: ETH) treasury strategy.

Benzinga

STERIS Stock: Is STE Outperforming the Healthcare Sector?

STERIS has outpaced the broader healthcare sector over the past year and analysts are reasonably bullish on its future prospects.

Barchart

Bottom 100 Stocks to Buy: Does Innovate Corp. Qualify as a Sum-of-the-Parts Play?

Sitting in 64th position in Barchart’s Bottom 100 Stocks to Buy is Innovate Corp., a penny stock controlled by one of the Glazer family, the owners of the Tampa Bay Bucs and controlling shareholders of Manchester United. It could be a sum-of-the-parts play. Here’s why.

Barchart

Why Diversity Matters in Life Sciences Teams and How to Achieve It

The best talent is often hard to acquire and retain, with the best candidates having multiple job offers to choose from.

inkl

Hyderabad Pharma City project scrapped, govt to set up 10 pharma villages: Sridhar Babu

Congress government in Telangana scraps Hyderabad Pharma City project, opting for 10 pharma villages across the state.

The Hindu

How Two Rattlesnake Bites and Scholarships Led This Doctor to His Calling

Serendipity played a role, too, in Albert ‘Bert’ McBride’s rise from poisonous-snake expert to urologist. At 85, he’s still in practice.

Kiplinger

Croda forecasts narrower profits for 2023 after record year

Customer destocking highlighted by East Yorkshire giant

Birmingham Post

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Life sciences sector to get £650m ‘war chest’ in new funding package

It is the latest effort to follow up on the prime minister’s pledge to turn the UK into a ‘science superpower’

The Hindu

TS keen to boost Life Sciences ecosystem

KTR chairs meet with pharma industry leaders, WEF team

The Hindu

BioAsia 2023 to open on Feb. 24

To bring together life sciences and healthcare leaders, academia, startups, regulators, investors

Benzinga

604% Revenue Increase: Flora Growth Reports Financial Results For First Half Of 2022

Flora Growth Corp. (NASDAQ: FLGC), a manufacturer and distributor of global cannabis products and brands, reported late Monday its financial and operating results for the six months ended June 30, 2022.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

The Daily Biotech Pulse: FDA Committee Backs Moderna Shot For 5-17 Years, 180 Life Sciences Stock Plunges, Pfizer's Posts Disappointing Paxlovid Data

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Becton Dickinson Raises FY22 Guidance As Q2 Earnings Top Estimates

Becton Dickinson and Co (NYSE:BDX) reported Q2 FY22 revenues of $5.01 billion, up 2.1% Y/Y (3.9% on a currency-neutral basis), better than the consensus of $4.85 billion. Revenue was driven by base revenue growth of 8.2% as reported, 10.2% currency-neutral, partially offset by the decline in COVID-only testing revenues to $214 million…

Benzinga

Corning Surpasses Q1 Consensus Backed By Strength Across Optical, Display Businesses

Corning Inc (NYSE:GLW) reported first-quarter FY22 core sales growth of 15% year-on-year to $3.7 billion, above the consensus of $3.57 billion. Display Technologies sales grew 11% Y/Y to $959 million, driven by a favorable glass pricing environment. Optical Communications sales rose 28% Y/Y to $1.2 billion as 5G, broadband, and cloud computing continue…

The Hindu

Bharat Serums and Vaccines to set up ₹200 cr. facility in Genome Valley

Women health products, rabies vaccines, immunoglobulins to be made at the injectable and vaccine plant

Benzinga

Corning Shares Gain On Q4 Beat, Robust Outlook

Corning Inc (NYSE:GLW) reported fourth-quarter FY21 core sales growth of 12% year-on-year to $3.71 billion, above the consensus of $3.59 billion. Display Technologies sales grew 12% Y/Y to $942 million due to a favorable glass pricing environment. Optical Communications sales rose 24% Y/Y to $1.2 billion as 5G, broadband, and cloud computing continue…

The Hindu

BioAsia to open on February 24

‘Future Ready’ theme of the 2-day event focused on Life Sciences

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.